Business
LGC Capital's Australian Medical Cannabis LP Little Green Pharma becomes market leader by becoming first Australian company authorized to sell locally-grown and manufactured Medicinal cannabis
LGC Capital's Australian Medical Cannabis LP Little Green Pharma becomes market leader by ...
About this update from Elixxer Ltd.
[{"type":"text","content":"\n\n\n\nLGC Capital's Australian Medical Cannabis LP Little Green Pharma becomes market leader by becoming first Australian company authorized to sell locally-grown and manufactured Medicinal cannabis\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\n\nCanada NewsWire\nMONTREAL, Aug. 23, 2018\n\n\n\n/NOT FOR DISTRIBUTION IN THE UNITED STATES/\n\n\nLittle Green Pharma becomes first Australian company authorized to sell locally-grown and manufactured medicinal cannabis products.\nLGP becomes Australian market leader with this milestone.\nLGP's medical products are now available for Australian patients by prescription.\nLGP aims to offer the most affordable products on the Australian market and displace more expensive imported products.\n\n\nMONTREAL, Aug. 23, 2018 /CNW Telbec/ - LGC Capital Ltd. (TSXV: LG) (\"LGC\") is pleased to announce that its Australian medical cannabis company Little Green Pharma (LGP), has become the market leader in Australia by becoming the first Australian company to locally-grow and produce medicinal cannabis products for sale to Australian patients. The first products are now ready to be delivered to patients. Their full media release is shown below.\n\n\n \n \n\n \nLGP is making high quality and reliable medicinal cannabis products available to Australians. The medicines are cultivated, without pesticides, in a hydroponic facility in Western Australia's southwest region and processed in a manufacturing facility near Perth. \n\nThe products have been subject to extensive assessment and testing based on the Australian TGA regulation, before being distributed under Australia's tightly controlled medical prescription system. \n\nUnder the Australian system, medicinal cannabis products must be prescribed by medical practitioners and sold by registered pharmacists. \n\nMedicinal cannabis is currently being prescribed in Australia for a variety of conditions with the Commonwealth Department of Health developing clinical guidance documents for the treatment of epilepsy, multiple sclerosis, chemotherapy-induced nausea and...